2009
DOI: 10.1158/0008-5472.can-08-3660
|View full text |Cite
|
Sign up to set email alerts
|

Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery

Abstract: Progression in pediatric brain tumor growth is thought to be the net result of signaling through various protein kinasemediated networks driving cell proliferation. Defining new targets for treatment of human malignancies, without a priori knowledge on aberrant cell signaling activity, remains exceedingly complicated. Here, we introduce kinome profiling using flow-through peptide microarrays as a new concept for target discovery. Comprehensive tyrosine kinase activity profiles were identified in 29 pediatric b… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
120
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 112 publications
(126 citation statements)
references
References 45 publications
5
120
1
Order By: Relevance
“…This new array platform permits interrogation of kinase activity in small volume, low concentration samples, using a chip preprinted with consensus phosphorylation sequences for specific kinases. Two chips are available, one for tyrosine kinases (STK), and another for serine/threonine kinases (STK) (Hilhorst et al, 2009;Sikkema et al, 2009). Each chip has B140 unique kinase targets; thus, the pattern and intensity of phosphorylation on the chip yields activity data for potentially hundreds of protein kinases.…”
Section: Measuring Kinase Activity: Kinome Arraysmentioning
confidence: 99%
“…This new array platform permits interrogation of kinase activity in small volume, low concentration samples, using a chip preprinted with consensus phosphorylation sequences for specific kinases. Two chips are available, one for tyrosine kinases (STK), and another for serine/threonine kinases (STK) (Hilhorst et al, 2009;Sikkema et al, 2009). Each chip has B140 unique kinase targets; thus, the pattern and intensity of phosphorylation on the chip yields activity data for potentially hundreds of protein kinases.…”
Section: Measuring Kinase Activity: Kinome Arraysmentioning
confidence: 99%
“…Comprehensive descriptions of mammalian kinomes have become possible through the sequential spotting of kinase substrates, encompassing the entire human kinome, on a carrier. When such peptide arrays are incubated with cellular lysates and radioactive ATP, kinases active in the lysate will phosphorylate their respective substrates, and upon determining substrate phosphorylation using a phosphoimager, comprehensive descriptions of cellular signaling may be generated (27,28). From the kinome profiles obtained before and after bungee jumping, a noncanonical (also termed nongenomic) glucocorticoid signature stands out.…”
Section: Discussionmentioning
confidence: 99%
“…First, pimozide does not inhibit Jak family kinases in an isolated in vitro kinase assays (Table 1). Second, its pattern of inhibition of substrate phosphorylation catalyzed by extracts from Jak2 V617F-expressing cells using the PamChip tyrosine kinase microarray system (PamGene, Den Bosch, Netherlands) 11 is clearly distinct from that mediated by a Jak inhibitor (including no inhibition of the phopshorylation of the Jak2 peptide by pimozide; Figure 1b). Pimozide did inhibit phosphorylation of a peptide derived from Jak1, though this likely occurred through an indirect mechanism.…”
mentioning
confidence: 99%